Compare Medtronic PLC (MDT) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs NextEra Energy, Inc. — how do they compare? Medtronic PLC trades at $83.21 (market cap $106.61B), while NextEra Energy, Inc. trades at $88 (market cap $183.53B). The key difference: NextEra Energy, Inc. is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | NEE | |
|---|---|---|
Market Cap | $106.61B | $183.53B |
Sector | Health | Utilities |
52-Week High | $105.35 | $97.88 |
52-Week Low | $73.75 | $69.77 |
Enterprise Value | $125.36B | $285.94B |
Dividend Yield | 3.46% | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
NextEra Energy (NEE) trades at $87.82, down 1.1% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported mixed Q1 2026 earnings, beating estimates with $1.09 EPS versus $1.03 expected, but missed Q4 2025. Revenue for 2025 reached $27.41B with a net income margin of 29.37%. Recent news highlights a planned $59B annual capex through 2032 and a merger filing with Dominion Energy to expand market reach.
Outlook remains positive with analyst consensus price target of $101.88 (16% upside), supported by 66.7% buy ratings. Key risks include high capital expenditures straining cash flow and regulatory hurdles for the Dominion merger. The stock offers growth potential from clean energy investments but faces execution and debt concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
